Clinical trial
Adipose-Derived Stem Cells (ADSCs) Injections for Liver Cirrhosis
NCT04088058 is registered in ClinicalTrials.gov with Gwo Xi Stem Cell Applied Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adipose-Derived Stem Cells (ADSCs) Injections for Liver Cirrhosis
- Lead sponsor
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 16, 2019
- Completion date
- April 19, 2025
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.